| Host: | HEK293 |
| Note: | STRICTLY FOR FURTHER RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description : | Recombinant-COV2 Nucleocapsid protein N B.1.1.529 (Omicron)-His-Tag protein was developed from hek293 and has a target region of His-Tag. For use in research applications. |
| Conjugation: | Unconjugated |
| Formulation: | Lyophilised from 0.2 µm filtered PBS solution pH7.4 |
| Dilution Range: | Spin the vial and reconstite in distilled water to a concentration not less than 0.1 mg/mL. This can then be diluted into other buffers. |
| Storage Instruction: | The lyophilized protein is stable for at least 1 year from date of receipt at-20°C. NA |
| Endotoxin: | Endotoxin content was assayed using a LAL gel clot method. Endotoxin level was found to be less than 0.1 ng/µg (1EU/µg). NA |
| Immunogen Region: | 1-419aa |
| Immunogen: | DNA sequence encoding extracellular fragment[1-419] of COV2 Nucleocapsid protein (B.1.1.529/Omicron) variant (P13L, E31 R32S33 deletion, R203K, G204R) including a C terminal polyHis tag was expressed in HEK cells. NA |
| Background | The lyophilized protein is stable for at least 2 years from date of receipt at-20°C. |
Information sourced from Uniprot.org
